Trial Profile
International, Multicenter Study of a Twenty-eight Week, Open-label, Titrated Oral Lixivaptan Administration in Patients With Chronic Hyponatraemia: Extension to Studies CK-LX3401, 3405, and 3430
Status:
Completed
Phase of Trial:
Phase III
Latest Information Update: 05 Jun 2015
Price :
$35
*
At a glance
- Drugs Lixivaptan (Primary)
- Indications Hyponatraemia
- Focus Adverse reactions; Registrational
- Sponsors Cardiokine
- 14 Aug 2014 New trial record
- 20 Jun 2011
- 24 Nov 2010